GAMMA Investing LLC Boosts Stock Position in Agilent Technologies, Inc. $A

Key Points

• GAMMA Investing LLC increased its holdings in Agilent Technologies by 48.8% during the second quarter, owning 7,978 shares valued at approximately $941,000 as per the latest SEC filing.
• The company recently declared a quarterly dividend of $0.248, representing an annualized dividend yield of 0.8%, with the payment scheduled for October 22nd.
• Agilent Technologies reported earnings of $1.37 per share for the last quarter, meeting analyst expectations, and projects FY 2025 earnings guidance between $5.560 and $5.590 per share.

GAMMA Investing LLC grew its holdings in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 48.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,978 shares of the medical research company's stock after buying an additional 2,616 shares during the quarter. GAMMA Investing LLC's holdings in Agilent Technologies were worth $941,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Sunbelt Securities Inc. raised its holdings in Agilent Technologies by 640.0% in the fourth quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock valued at $30,000 after acquiring an additional 192 shares in the last quarter. Whipplewood Advisors LLC grew its holdings in Agilent Technologies by 286.2% during the 1st quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock worth $29,000 after acquiring an additional 186 shares in the last quarter. Wood Tarver Financial Group LLC bought a new stake in shares of Agilent Technologies in the 4th quarter worth about $34,000. Stone House Investment Management LLC acquired a new stake in shares of Agilent Technologies in the 1st quarter valued at about $30,000. Finally, Opal Wealth Advisors LLC bought a new position in shares of Agilent Technologies during the first quarter worth about $31,000.

Insider Buying and Selling at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,508 shares of the firm's stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total transaction of $177,099.52. Following the completion of the transaction, the chief executive officer owned 37,448 shares of the company's stock, valued at $4,397,893.12. This trade represents a 3.87% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Agilent Technologies Stock Down 0.3%

A stock opened at $125.99 on Wednesday. The firm's 50-day moving average is $120.63 and its two-hundred day moving average is $115.88. The company has a market capitalization of $35.72 billion, a price-to-earnings ratio of 29.58, a price-to-earnings-growth ratio of 3.93 and a beta of 1.24. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $153.84. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The business had revenue of $1.74 billion during the quarter, compared to analysts' expectations of $1.67 billion. During the same period last year, the firm posted $1.32 earnings per share. The business's revenue was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be paid a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, September 30th. Agilent Technologies's payout ratio is currently 23.24%.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. Barclays reissued an "equal weight" rating and issued a $125.00 price objective on shares of Agilent Technologies in a report on Friday, August 29th. Robert W. Baird boosted their price target on Agilent Technologies from $141.00 to $142.00 and gave the company an "outperform" rating in a report on Thursday, August 28th. TD Cowen raised their price objective on Agilent Technologies to $150.00 and gave the stock a "buy" rating in a research note on Thursday, May 29th. Wells Fargo & Company boosted their target price on shares of Agilent Technologies from $140.00 to $150.00 and gave the company an "overweight" rating in a research note on Monday, September 15th. Finally, JPMorgan Chase & Co. reduced their price target on shares of Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating on the stock in a research report on Thursday, May 29th. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company's stock. According to MarketBeat.com, Agilent Technologies has a consensus rating of "Moderate Buy" and an average target price of $140.08.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.